Ganirelix (Ganirelix Acetate) - Summary

GANIRELIX SUMMARY

Ganirelix Acetate Injection is a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin-releasing hormone (GnRH).

Ganirelix Acetate Injection is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.

See all Ganirelix indications & dosage >>

GANIRELIX NEWS HIGHLIGHTS

Media Articles Related to Ganirelix

Use Of Biased Language And Inaccurate Data About Male Factor Infertility On Fertility Clinic Websites In The USA
Source: Fertility News From Medical News Today [2008.11.24]

Is Socioeconomic Status Associated With Higher Infertility Costs?
Source: Fertility News From Medical News Today [2008.11.24]

Expert Warns Size Zero Trend Can Cause Infertility
Source: Fertility News From Medical News Today [2008.11.07]

Health Tip: Help Prevent Infertility
Source: MedicineNet Alcohol Abuse and Alcoholism Specialty [2008.11.03]

Study: Infertility Treatments No Help
Source: MedicineNet Polycystic Ovary Specialty [2008.08.08]

more >>

Published Studies Related to Ganirelix

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. [2006.03]

LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome. [2005.12]

Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. [2005.07]

A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. [2005.05]

A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. [2004.08]

more >>

Clinical Trials Related to Ganirelix

A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders [Recruiting]

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women [Recruiting]

The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration [Recruiting]

Compromised Microcirculation in Women With Polycystic Ovary Syndrome [Recruiting]

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation [Recruiting]

more >>